FF-10502 Uses, Dosage, Side Effects and more
FF-10502 is under investigation in clinical trial NCT02661542 (Study of FF-10502-01 in Patients With Advanced Solid Tumors and Lymphomas).
| Trade Name | FF-10502 |
| Generic | FF-10502 |
| Type | |
| Formula | C9H12FN3O3S |
| Weight | Average: 261.27 Monoisotopic: 261.058340595 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
